Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions
about
Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugsAddressing the Heterogeneity of Heart Failure in Future Randomized Trials.Developing therapies for heart failure with preserved ejection fraction: current state and future directionsIncidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study).Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomesAvailability of data when heart failure patients are admitted to hospice.Long-term survival for patients with acute decompensated heart failure according to ejection fraction findingsCardiac output as a potential risk factor for abnormal brain agingDiuretics as pathogenetic treatment for heart failure.Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic functionKey role of congestion in natural history of heart failureHospital variation in noninvasive positive pressure ventilation for acute decompensated heart failure.Heart Failure with Preserved Ejection Fraction: Persistent Diagnosis, Therapeutic Enigma.Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum.Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and OutcomesMagnitude of and Prognostic Factors Associated With 1-Year Mortality After Hospital Discharge for Acute Decompensated Heart Failure Based on Ejection Fraction FindingsComparison of Length of Stay, 30-Day Mortality, and 30-Day Readmission Rates in Medicare Patients With Heart Failure and With Reduced Versus Preserved Ejection FractionComparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%.Echocardiographic assessment of pressure volume relations in heart failure and valvular heart disease: using imaging to understand physiology.Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemiaTheodore E. Woodward Award: Coming in out of the rain. Relieving congestion in heart failure.Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy.Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction.Treatment of heart failure with preserved ejection fraction.Cardiorenal syndrome: new developments in the understanding and pharmacologic management.Prognostic factors in patients hospitalized for heart failure.Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists.Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review.Association of N-terminal pro-brain natriuretic peptide with contrast-induced acute kidney injury and long-term mortality in patients with heart failure and mid-range ejection fraction: An observation study.Diagnostic accuracy of 64 slice multidetector coronary computed tomographic angiography in left ventricular systolic dysfunction.Predictors and outcomes of heart failure with mid-range ejection fraction.Left ventricular global longitudinal strain predicts mortality and heart failure admissions in African American patients.The Initial Evaluation and Management of a Patient with Heart Failure.Congestion is the driving force behind heart failure.Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).Therapeutic outcomes for patients with aneurysmal subarachnoid hemorrhage complicated by Takotsubo cardiomyopathy.Extraction of Ejection Fraction from Echocardiography Notes for Constructing a Cohort of Patients having Heart Failure with reduced Ejection Fraction (HFrEF)Is heart failure with mid range ejection fraction (HFmrEF) a distinct clinical entity or an overlap group?
P2860
Q28085736-DB405519-E7D5-4D57-84A0-0FD82C3087F1Q30234708-A952EF25-B2C7-4C82-B010-F945C10A783BQ33639223-D9E3D465-7C17-435B-9CFB-E3871D39B015Q33685255-46A954F8-F695-4DA0-AF95-4CCBC99C7C08Q33740885-9BCAA23D-DEA7-46D3-936E-0F4E5D43A220Q34079581-85DBEB5C-5173-4AE9-88DF-9B60FF7CB67EQ34173702-276DB5C9-F57D-40CC-8519-5BA21AA5135DQ34583065-1B7A1558-1935-4362-BCE1-80B609C4AADBQ34622653-060749E6-29B4-4208-AFD3-50871C4B831CQ35147914-38ADAF0A-5DDD-42B3-BC8A-2E7270A555D6Q35178827-2BEA98AC-B00F-4E80-81FA-53B27AF56F83Q35281909-960C5E9B-EB46-4FF4-BA06-6EC409F55E81Q35536451-F91968EB-4C5D-4DA9-8181-84F8F5F0648EQ36167458-86B75EF7-7686-4461-BADC-E0F7749B3764Q36728719-043D93AC-3ADC-46B0-B4F6-BC46D4315D7DQ36836423-9C061CD9-9886-41F9-B98B-753A5D2582A2Q37018329-EE5856A0-632D-4646-8555-3B29BE6B75F3Q37082859-65EE18C1-D211-4DD4-9852-4F83170DFE8CQ37121912-1F199EA9-9592-4DA7-9BAF-6DBCE2575B51Q37183408-45C75EF1-3770-4ABB-89C2-DA84ADBD95EDQ37348166-96A2E683-0ACD-46B7-A0FB-70ED31C4CC06Q37408637-AD545BC6-E785-4819-AB51-D168C127F9E9Q37419451-70B4E633-0C7E-4A7D-9520-136B04B8E516Q37848405-80FC2F58-DE58-44E7-B8B3-6D6BCD9E6AEAQ38127668-E8E8A8A0-5FC1-491B-90D4-9B30B11A3137Q38152290-5D99AF37-3C2C-43EB-BFF8-8063EF3299CBQ38168120-3E81E3D9-0100-4ABB-BC7B-348D6BE14CBCQ38658569-16CFA3E1-DC39-4932-A173-C5CAF51B6685Q40302977-6F22B134-84C7-497B-B917-5CC6D0E22664Q40964050-305F7BAF-6850-406A-98DA-F0EF4E1A11CAQ46178786-4BECFCF4-1B68-4796-8E97-FB013F327E82Q46219377-024852D8-0F50-4744-87A7-460C985A73B3Q47552207-0CD80876-C0F3-4876-9452-5D8031046E5DQ47620108-413DB125-81FC-4D73-ABD2-B609FDF9F5BEQ50099011-E2343DBA-9E2C-477D-BF50-D4EE879529A4Q50798879-91706B5C-0F82-46DD-9356-449E2B6232C9Q51456089-FF1FC028-D416-4132-919B-87B395599B99Q58699512-3B368184-77D2-4943-B9C3-21377E9BB19AQ58761699-CC41A934-657A-40E0-86D7-07C19408FC18
P2860
Comparison of clinical features and outcomes of patients hospitalized with heart failure and normal ejection fraction (> or =55%) versus those with mildly reduced (40% to 55%) and moderately to severely reduced (<40%) fractions
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Comparison of clinical feature ...... erely reduced (<40%) fractions
@ast
Comparison of clinical feature ...... erely reduced (<40%) fractions
@en
type
label
Comparison of clinical feature ...... erely reduced (<40%) fractions
@ast
Comparison of clinical feature ...... erely reduced (<40%) fractions
@en
prefLabel
Comparison of clinical feature ...... erely reduced (<40%) fractions
@ast
Comparison of clinical feature ...... erely reduced (<40%) fractions
@en
P2093
P2860
P1476
Comparison of clinical feature ...... erely reduced (<40%) fractions
@en
P2093
Lynne W Stevenson
Margarita Lopatin
Nancy K Sweitzer
Roger M Mills
P2860
P304
P356
10.1016/J.AMJCARD.2007.12.014
P407
P50
P577
2008-02-20T00:00:00Z